News for SANUWAVE Health, Inc. (SNWV)

We came across a bullish thesis son SANUWAVE Health, Inc. (SNWV) on @rationalformula on X(Twitter). In this article, we will summarize the bulls’ thesis on SNWV. SANUWAVE Health, Inc. (SNWV)’s share was trading at $27.97 as of 28th May. SNWV’s trailing P/E was 2.44 according to Yahoo Finance. SANUWAVE ($SNWV) presents a compelling microcap investment opportunity with […]

Revenue: $10.3 million for Q4 2024, a 47% increase from $7 million in Q4 2023.Systems Sold: 135 systems in Q4 2024, a 71% increase from 79 systems in Q4 2023.A

Mar 21, 2025 / 12:30PM GMTOperator Good day, everyone, and welcome to today's Sanuwave earnings call. (Operator Instructions) Please note today's conference is

SANUWAVE Health, Inc. (NASDAQ:SNWV) Q4 2024 Results Conference Call March 21, 2025 8:30 AM ETCompany ParticipantsMorgan Frank - Chairman and Chief Executive...

SANUWAVE Health Inc (SNWV) released its 8-K filing on March 21, 2025, showcasing a remarkable financial performance for the fourth quarter and full year of 2024

Q4 2024 revenues were $10.3 million, up 47% from Q4 2023. This was an all-time quarterly record for the Company. Full year 2024 revenues were $32.6 million, up

SANUWAVE Health, Inc. (the "Company" or "SANUWAVE”) (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live

Trading Under the Ticker ”œSNWV” Expected to Begin on March 7, 2025 EDEN PRAIRIE, Minn., March 04, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the ”

On December 31, 2024, Solas Capital Management, LLC (Trades, Portfolio) executed a notable transaction by acquiring 713,752 shares of SANUWAVE Health Inc. This

Revenue: $9.4 million for Q3 2024, an increase of 89% year-over-year and 31% sequentially from Q2 2024.Gross Margin: 75.5% for Q3 2024, up from 71.5% in the sa

Nov 08, 2024 / 01:30PM GMTOperator Please stand by. Your program is about to begin. If you need assistance during your conference today, please press star zero.

Revenue: Achieved record quarterly revenue of $9.4 million in Q3 2024, marking an 89% increase from Q3 2023.Gross Margin: Improved to 75.5% in Q3 2024, up from

EDEN PRAIRIE, Minn., Nov. 04, 2024 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (the

Overview of Recent Transaction On November 1, 2024, Opaleye Management Inc. (Trades, Portfolio) made a significant addition to its investment portfolio by acqui

Opaleye management purchases $438,902 in SANUWAVE Health shares

Overview of the Recent Transaction On October 18, 2024, Opaleye Management Inc. (Trades, Portfolio) made a significant new investment in SANUWAVE Health Inc. (S

**media[440618]**

1-for-375 reverse stock split effective at market open today Exchanged $43.2 million in principal amount of convertible notes and warrants previously...